Fosamax (Alendronate) HSA/FSA Eligibility and Submission Guide

At a glance
- Drug / Fosamax (alendronate sodium), oral bisphosphonate for osteoporosis
- HSA eligible / Yes. Prescription drugs are qualified medical expenses under IRS Publication 502
- FSA eligible / Yes. Same IRS rule applies to all FSA types (healthcare and limited-purpose with medical expenses)
- Generic available / Yes. Alendronate sodium 70 mg weekly tablets are widely available from multiple manufacturers
- Typical generic cash price / $10, $30 per month at major pharmacy chains without insurance
- Brand-name cash price / Up to $300+ per month; rarely the cheapest option
- Key discount tools / GoodRx, Mark Cuban Cost Plus Drugs, NeedyMeds, manufacturer PAP
- USPSTF recommendation / Grade B recommendation for osteoporosis screening in women 65+ (2018 guideline)
- Primary FDA approval year / 1995 (Merck); generic approvals ongoing
- Claim submission deadline / Typically December 31 of plan year or grace period end; check your Summary Plan Description
Is Alendronate an HSA- and FSA-Eligible Expense?
Alendronate is eligible for reimbursement under both HSAs and FSAs. The IRS defines qualified medical expenses in Publication 502, and prescription drugs obtained with a valid prescription have been included in that list since the Affordable Care Act removed over-the-counter drugs without a prescription from the list in 2011. Because alendronate requires a prescription under FDA labeling, it meets that standard automatically. The FDA approved alendronate sodium (Fosamax) in 1995 for the treatment and prevention of osteoporosis in postmenopausal women and for glucocorticoid-induced osteoporosis.
The IRS Rule That Makes This Work
IRS Publication 502 states: "You can include in medical expenses amounts you pay for prescribed drugs and medicines." A prescribed drug is one that requires a prescription under federal or state law. Alendronate falls squarely within that definition. There is no annual spending cap specific to a single drug; you can reimburse the full cost of your prescription fills as long as you have remaining HSA or FSA funds. IRS guidance on HSA contribution limits for 2026 set the self-only HSA contribution ceiling at $4,300 and the family ceiling at $8,550.
HSA vs. FSA: Which Works Better for Alendronate?
Both account types cover alendronate equally. The difference is flexibility. HSA funds roll over indefinitely and can be invested, while FSA funds typically have a use-it-or-lose-it deadline (December 31, with an optional 2.5-month grace period or $660 rollover at plan discretion). For a chronic medication like alendronate, taken long-term (often 3 to 5 years per clinical practice), an HSA offers a strategic advantage: unused contributions compound tax-free and can offset future fills. The AACE/ACE 2020 Clinical Practice Guidelines for the Diagnosis and Treatment of Postmenopausal Osteoporosis recommend bisphosphonate therapy for 3 to 5 years in most patients, which means predictable, multi-year drug costs.
How to Submit a Claim for Alendronate
Submission is straightforward. Most HSA and FSA administrators accept a claim within minutes when you upload the required documents through their online portal or mobile app.
Documents You Need
Three documents cover nearly every plan administrator's requirements:
- Pharmacy receipt or printout. The receipt must show the drug name, date of service, patient name, and the amount you paid out of pocket. Most pharmacy chains can print a 12-month prescription history on request.
- Explanation of Benefits (EOB). Some administrators require an EOB from your insurer showing what insurance did not cover. If you paid 100% cash (uninsured or using a discount card), a receipt alone is usually sufficient.
- Prescription label copy. Less commonly required, but keep it. The label confirms the drug was dispensed under a valid prescription.
Step-by-Step Submission
- Fill your alendronate prescription at any licensed U.S. Pharmacy.
- Pay out of pocket or use a split-payment strategy (see the cost section below).
- Log in to your HSA or FSA administrator's portal (common platforms: HealthEquity, WEX, Optum Bank, Paychex, HSA Bank).
- Select "Submit a Claim" or "Request Reimbursement."
- Upload your pharmacy receipt or EOB.
- Enter the expense date (date of service, not date of payment).
- Submit. Reimbursement to your linked bank account typically posts in 3 to 5 business days.
If your employer issued a debit card linked to your FSA, you can swipe that card directly at the pharmacy counter. The card's merchant-category-code system will approve most prescription transactions automatically, with no separate submission needed.
Common Rejection Reasons and Fixes
Rejected claims almost always trace back to one of three causes: the receipt is missing the drug name, the date of service falls outside the plan year, or the administrator incorrectly flags the item as not prescription-only. For any rejection citing the third reason, submit a Letter of Medical Necessity (LMN) from your prescribing physician. The LMN does not need to be elaborate. A one-paragraph note on letterhead confirming the diagnosis (e.g., postmenopausal osteoporosis, ICD-10 code M81.0) and the prescription is sufficient for most administrators. Clinical criteria for alendronate prescribing are well-established in the literature, and a physician LMN citing osteoporosis diagnosis should resolve any ambiguity.
Why Alendronate's Clinical Evidence Supports Long-Term Cost Planning
Understanding why your physician prescribed alendronate for years, not weeks, helps you plan your HSA or FSA spending accurately.
The Fracture Risk Reduction Data
The Fracture Intervention Trial (FIT), which enrolled 2,027 postmenopausal women with low bone mass, found that alendronate reduced the risk of hip fracture by 51% and vertebral fracture by 47% over 3 years compared with placebo [P<0.001 for both endpoints]. The primary FIT publication is available via PubMed (PMID 8950879). These are among the largest fracture-risk reductions documented for any pharmacologic intervention in osteoporosis.
How Long Will You Need the Drug?
The American College of Physicians 2017 guideline on pharmacologic treatment of primary osteoporosis states: "ACP recommends that clinicians treat osteoporotic women with pharmacologic therapy for 5 years." After 5 years, a drug holiday may be appropriate for lower-risk patients, with resumption based on bone mineral density (BMD) monitoring. Plan your HSA contributions accordingly. At a generic cash price of roughly $15 to $25 per 30-day supply, five years of weekly 70 mg alendronate costs approximately $900 to $1,500 total at cash prices before discounts.
USPSTF Screening Recommendation
The U.S. Preventive Services Task Force (USPSTF) issued a Grade B recommendation in 2018 for osteoporosis screening with bone density measurement (DEXA scan) in women aged 65 and older. That recommendation is searchable on the USPSTF website. Screening leads to diagnosis, which leads to prescribing. The DEXA scan itself is also HSA/FSA eligible as a preventive screening service.
How to Get Fosamax or Alendronate Cheaper
Generic alendronate sodium is one of the least expensive osteoporosis drugs on the market. Brand-name Fosamax carries no clinical advantage over generics and costs substantially more. The FDA maintains a current list of approved generic alendronate products. Below are the main strategies for reducing your out-of-pocket costs in 2026.
Generic Substitution First
Ask your pharmacist to dispense alendronate sodium 70 mg tablets (generic) rather than Fosamax. In most states, automatic generic substitution is permitted unless the prescriber writes "dispense as written." Generic alendronate is therapeutically equivalent: the FDA's Orange Book assigns it an AB rating, confirming bioequivalence. Cash prices at major chains can be as low as $9 for a 4-tablet (28-day) supply. The FDA Orange Book entry for alendronate confirms AB-rated generics are available.
Prescription Discount Cards and Platforms
Discount cards function as a negotiated cash price, separate from insurance. They cannot be combined with insurance in the same transaction, but they can be used instead of insurance when the discount price is lower than your copay.
- GoodRx: Prices for generic alendronate 70 mg at many pharmacies range from $9 to $18 for a 4-week supply. GoodRx prices are updated in real time.
- Mark Cuban Cost Plus Drugs (costplusdrugs.com): As of 2026, alendronate 70 mg 4-tablet supplies are listed at Cost Plus pricing (cost + 15% markup + $3 dispensing fee). Prices vary but are often below $10.
- NeedyMeds: The NeedyMeds Drug Discount Card provides free savings at over 59,000 pharmacies and is particularly useful for uninsured patients.
You can pay with any of these discount cards and then submit the pharmacy receipt to your HSA or FSA for reimbursement, as long as the receipt shows the drug name, date, and amount paid. The IRS does not require you to use insurance before tapping your HSA or FSA.
Manufacturer Patient Assistance Programs
Merck, the original Fosamax manufacturer, does not currently operate a PAP for brand-name Fosamax in most markets because generic alendronate is so widely available and inexpensive. If your insurer specifically requires brand-name Fosamax (rare) and you face financial hardship, contact Merck directly through the NeedyMeds PAP directory. Generic manufacturers do not operate PAPs, but discount cards close the gap for most patients.
Splitting a 70 mg Tablet for the Daily 35 mg Dose?
Alendronate is available as both a daily 10 mg dose and a weekly 70 mg dose. The weekly formulation is the clinical standard because adherence is substantially better with once-weekly dosing. A JAMA Internal Medicine study (PMID 15477439) found that medication possession ratios for bisphosphonates were significantly higher with weekly versus daily regimens, which matters clinically because non-adherence attenuates fracture protection. Do not attempt to split the 70 mg tablet for two 35 mg doses; the tablet is not scored for splitting and the absorption profile assumes a single weekly dose.
Insurance Coverage Basics for Alendronate
Most commercial insurance plans place generic alendronate on Tier 1 or Tier 2, with copays ranging from $0 to $20 per month. Medicare Part D covers alendronate on nearly all formularies. CMS Part D formulary data confirm widespread coverage for bisphosphonates. Medicaid coverage varies by state but is near-universal for alendronate given its low acquisition cost and established clinical benefit.
When Insurance Requires Prior Authorization
Prior authorization (PA) for generic alendronate is uncommon but not impossible. Some plans require documentation of a DEXA scan result (T-score at or below -2.5, meeting the WHO definition of osteoporosis) before approving coverage. The WHO diagnostic criteria for osteoporosis are defined by a T-score <-2.5 SD below the young adult mean, as published in the WHO Technical Report. Your prescriber's office can submit the DEXA report as PA supporting documentation. Approval typically takes 24 to 72 hours.
Medicare Part D and the Low-Income Subsidy
Patients receiving the Low-Income Subsidy (LIS, also called "Extra Help") under Medicare Part D may pay $0 to $4.50 per monthly fill for generic alendronate in 2026. If you or a family member is near the income threshold, SSA's Extra Help program page explains how to apply. That $0 copay cannot be reimbursed through an HSA (you have no out-of-pocket expense), but other osteoporosis-related costs, including DEXA scans and clinic visits, remain HSA eligible.
Combining HSA/FSA With Other Savings Tools
Stacking multiple savings strategies is legal and often results in near-zero out-of-pocket cost for generic alendronate.
The Discount-Card-Plus-HSA Stack
Pay for your alendronate fill using a GoodRx or Cost Plus Drugs price (not insurance). Keep the itemized receipt. Submit that receipt to your HSA for reimbursement. You receive the low negotiated drug price AND the tax benefit of HSA reimbursement. On a $12 fill for a patient in the 22% federal tax bracket, the effective cost after HSA reimbursement is approximately $9.36.
FSA Deadline Planning for Chronic Use
Because alendronate is taken long-term, you can pre-fund your FSA with a predictable annual drug cost. If your plan allows a $3,200 healthcare FSA contribution (2026 IRS limit), even a full year of alendronate plus your DEXA scan ($150 to $350 self-pay) stays well within one year's FSA allocation. Submit DEXA receipts to FSA separately; the scan is a qualified diagnostic expense under IRS Publication 502.
The HealthRX clinical team developed this four-question decision framework for patients deciding how to pay for alendronate:
- Does your insurance cover generic alendronate at a copay below $15/month? If yes, pay with insurance and reimburse the copay via HSA/FSA.
- Is your insurance copay above $15/month? Compare the GoodRx or Cost Plus price. Use whichever is lower, then reimburse via HSA/FSA.
- Do you have an HSA with rollover funds? Prioritize HSA reimbursement over FSA to preserve FSA funds for higher-cost items with deadlines.
- Are you uninsured? Use Cost Plus Drugs or GoodRx at the pharmacy counter, pay cash, and reimburse from HSA or FSA with your receipt.
Special Populations and Coverage Considerations
Glucocorticoid-Induced Osteoporosis
Patients on long-term corticosteroids (prednisone 5 mg/day or more for 3+ months) face accelerated bone loss. The ACR 2022 Guideline for the Prevention and Treatment of Glucocorticoid-Induced Osteoporosis recommends bisphosphonate therapy for high-risk patients taking glucocorticoids. Alendronate is a first-line option in this population. Insurance PA criteria may reference the ACR guideline; having a copy of the guideline citation available can speed approvals.
Men With Osteoporosis
Alendronate is FDA-approved for osteoporosis in men. A randomized controlled trial published in NEJM (PMID 10979893) demonstrated that alendronate increased bone mineral density and reduced vertebral fracture risk in men with osteoporosis. Insurance coverage and HSA/FSA eligibility rules are identical for men and women. The USPSTF has not issued a Grade B or higher screening recommendation for men, which may affect whether a DEXA scan is covered without cost-sharing under the ACA's preventive care benefit; however, alendronate itself remains fully HSA/FSA eligible regardless of sex.
Paget's Disease of Bone
Alendronate 40 mg daily for 6 months is also FDA-approved for Paget's disease of bone. This is a shorter, higher-dose course. HSA and FSA eligibility is identical. Costs are higher per-fill for the 40 mg daily formulation, making HSA or FSA reimbursement even more valuable for this indication.
Record-Keeping Requirements
The IRS requires you to retain documentation supporting HSA distributions for as long as the statute of limitations remains open (generally 3 years after filing). Store pharmacy receipts as PDFs. Most FSA administrators archive your claims electronically, but do not rely solely on the administrator's records. If audited, you must produce documentation showing the expense was a qualified medical expense, the amount paid, and the date. A pharmacy's 12-month prescription history printout covers all of these requirements for a full plan year in a single document.
The IRS HSA audit guidance summarized in Revenue Procedure 2004-22 confirms that account holders, not administrators, bear the burden of proof for qualified distributions.
Frequently asked questions
›Can I use HSA/FSA for Fosamax?
›Does alendronate require a Letter of Medical Necessity for FSA reimbursement?
›Can I use a GoodRx coupon and then get reimbursed by my HSA?
›What is the cheapest way to get alendronate in 2026?
›Is brand-name Fosamax better than generic alendronate?
›Does Medicare Part D cover alendronate?
›How long do I need to take alendronate?
›What documents do I need to submit an HSA claim for alendronate?
›Can I use a Limited-Purpose FSA for alendronate?
›Can my HSA pay for a DEXA bone density scan?
›What happens if I pay for alendronate with HSA funds and the IRS audits me?
›Is alendronate covered for men under HSA/FSA rules?
References
- U.S. Food and Drug Administration. Fosamax (alendronate sodium) NDA 019268 approval history. https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=019268
- Internal Revenue Service. Publication 502: Medical and Dental Expenses (2025 edition). https://www.irs.gov/pub/irs-pdf/p502.pdf
- Internal Revenue Service. IR-2025-77: HSA contribution limits for 2026. https://www.irs.gov/pub/irs-news/ir-2025-77.pdf
- Black DM, Cummings SR, Karpf DB, et al. Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures (Fracture Intervention Trial). Lancet. 1996;348(9041):1535-1541. PMID: 8950879. https://pubmed.ncbi.nlm.nih.gov/8950879/
- Qaseem A, Forciea MA, McLean RM, et al. Treatment of low bone density or osteoporosis to prevent fractures in men and women: A Clinical Practice Guideline from the American College of Physicians. Ann Intern Med. 2017;166(11):818-839. PMID: 28492856. https://pubmed.ncbi.nlm.nih.gov/28492856/
- U.S. Preventive Services Task Force. Osteoporosis to prevent fractures: Screening (2018). https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/osteoporosis-screening
- Siris ES, Selby PL, Saag KG, et al. Impact of osteoporosis treatment adherence on fracture rates in North America and Europe. Am J Med. 2009;122(2 Suppl):S3-13. PMID: 15477439. https://pubmed.ncbi.nlm.nih.gov/15477439/
- Buckley L, Guyatt G, Fink HA, et al. 2017 American College of Rheumatology Guideline for the Prevention and Treatment of Glucocorticoid-Induced Osteoporosis. Arthritis Care Res. 2022;74(5):1-20. PMID: 35380198. https://pubmed.ncbi.nlm.nih.gov/35380198/
- Orwoll E, Ettinger M, Weiss S, et al. Alendronate for the treatment of osteoporosis in men. N Engl J Med. 2000;343(9):604-610. PMID: 10979893. https://pubmed.ncbi.nlm.nih.gov/10979893/
- WHO Study Group. Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. WHO Technical Report Series 843. 1994. PMID: 10549285. https://pubmed.ncbi.nlm.nih.gov/10549285/
- Centers for Medicare and Medicaid Services. Medicare Part D prescription drug coverage: General information. https://www.cms.gov/medicare/prescription-drug-coverage/prescriptiondrugcovgenin
- Internal Revenue Service. Revenue Procedure 2004-22: HSA substantiation requirements. https://www.irs.gov/irb/2004-15_IRB
- NeedyMeds. Drug Discount Card and Patient Assistance Program Directory. https://www.needymeds.org/drug-discount-card
- American Association of Clinical Endocrinologists / American College of Endocrinology. Clinical Practice Guidelines for the Diagnosis and Treatment of Postmenopausal Osteoporosis. 2020. https://www.aace.com/files/osteoporosis-guidelines.pdf